# An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis

> **NCT03656068** · PHASE2 · COMPLETED · sponsor: **Pinnacle Clinical Research, PLLC** · enrollment: 21 (actual)

## Conditions studied

- Non-alcoholic Steatohepatitis
- Fatty Liver
- Fibrosis, Liver
- Compensated Cirrhosis

## Interventions

- **DRUG:** Nitazoxanide 500mg BID

## Key facts

- **NCT ID:** NCT03656068
- **Lead sponsor:** Pinnacle Clinical Research, PLLC
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-04
- **Primary completion:** 2020-11-25
- **Final completion:** 2020-11-25
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2022-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03656068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03656068, "An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT03656068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*